Amgen Inc (AMGN)
271.91
+2.98
(+1.11%)
USD |
NASDAQ |
Apr 22, 16:00
271.96
+0.05
(+0.02%)
After-Hours: 20:00
Amgen Market Cap: 145.72B for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 145.72B |
| April 19, 2024 | 144.12B |
| April 18, 2024 | 140.81B |
| April 17, 2024 | 141.52B |
| April 16, 2024 | 142.36B |
| April 15, 2024 | 142.29B |
| April 12, 2024 | 143.24B |
| April 11, 2024 | 144.70B |
| April 10, 2024 | 142.80B |
| April 09, 2024 | 144.89B |
| April 08, 2024 | 144.27B |
| April 05, 2024 | 144.67B |
| April 04, 2024 | 143.67B |
| April 03, 2024 | 147.07B |
| April 02, 2024 | 148.03B |
| April 01, 2024 | 151.69B |
| March 28, 2024 | 152.37B |
| March 27, 2024 | 153.43B |
| March 26, 2024 | 151.01B |
| March 25, 2024 | 150.50B |
| March 22, 2024 | 148.00B |
| March 21, 2024 | 148.42B |
| March 20, 2024 | 146.33B |
| March 19, 2024 | 145.63B |
| March 18, 2024 | 145.18B |
| Date | Value |
|---|---|
| March 15, 2024 | 144.09B |
| March 14, 2024 | 145.52B |
| March 13, 2024 | 147.91B |
| March 12, 2024 | 148.20B |
| March 11, 2024 | 147.57B |
| March 08, 2024 | 146.71B |
| March 07, 2024 | 146.23B |
| March 06, 2024 | 148.23B |
| March 05, 2024 | 148.26B |
| March 04, 2024 | 149.73B |
| March 01, 2024 | 150.23B |
| February 29, 2024 | 146.75B |
| February 28, 2024 | 148.70B |
| February 27, 2024 | 149.25B |
| February 26, 2024 | 153.47B |
| February 23, 2024 | 154.98B |
| February 22, 2024 | 152.83B |
| February 21, 2024 | 151.91B |
| February 20, 2024 | 151.94B |
| February 16, 2024 | 152.04B |
| February 15, 2024 | 154.92B |
| February 14, 2024 | 155.45B |
| February 13, 2024 | 155.67B |
| February 12, 2024 | 157.79B |
| February 09, 2024 | 156.02B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
101.68B
Minimum
May 31 2019
173.77B
Maximum
Feb 01 2024
132.69B
Average
132.80B
Median
Jun 08 2020
Market Cap Benchmarks
| Gilead Sciences Inc | 83.42B |
| Johnson & Johnson | 359.35B |
| Eli Lilly and Co | 695.32B |
| Merck & Co Inc | 321.49B |
| Vertex Pharmaceuticals Inc | 103.29B |
Market Cap Related Metrics
| PE Ratio | 21.77 |
| PS Ratio | 5.187 |
| PEG Ratio | 6.938 |
| Price to Book Value | 23.38 |
| Price to Free Cash Flow | 19.87 |
| Price | 271.91 |
| Earnings Yield | 4.59% |
| PEGY Ratio | 3.447 |
| Operating PE Ratio | 18.52 |
| Normalized PE Ratio | 21.77 |